Oct. 2, 2025

The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) Imaging Network, managed by the ACR Center for Research and Innovation, offers participating imaging facilities exclusive access to discounted FDA-cleared AI tools and data visualization resources— to enhance Alzheimer’s imaging workflows and patient safety.

With 41 imaging facilities already participating, another 72 in start-up, and 3,184 patients enrolled from 115 referring dementia practices nationwide, ALZ-NET supports real-world evidence generation to inform FDA safety assessments and clinical guidelines – including appropriate PET use and MR safety.

Imaging facilities are invited to contribute longitudinal brain imaging data from patients receiving FDA-approved Alzheimer’s treatments.

Join the ALZ-NET Interest List today.

Related ACR News

  • Radiology’s Fight Against Prior Authorization Delays

    ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.

    Read more
  • ACR Supports Medicaid Coverage of Lung Cancer Screening

    ACR-backed bill would mandate Medicaid lung cancer screening, expand cessation coverage, ban prior auth—aiming to save lives and reduce disparities.

    Read more
  • Patient-Centered Imaging Care Led by Radiologists

    ACR helps its state chapters fight scope of practice expansion, such as helping to oppose bills in state legislatures that would allow non-physicians to practice independently.

    Read more